Ymmunobio company logo with antibody symbol and text in blue and red on transparent background
Ymmunobio company logo with antibody symbol and text in white on transparent background
Contact

 /   News

Latest developments updates & insights

News

Latest news

Stay informed with the latest company announcements, research milestones & scientific publications from Ymmunobio.

All news

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Drug Discovery & Development

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR antibodies

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Fierce Biotech: Appointment of Michel Janicot

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Ymmunobio Appoints Dr. Michel Janicot as Chief Development Officer

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy …

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Ymmunobio selected by BIO-Europe to participate in its Start-up Spotlight Session